Search research articles
Contact Us
Filters
Showing results (101-110 of 211) with videos related to
Page
of 22
Sort By:
British Journal of Haematology
|
July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
Reshma Shringarpure, Laurence Catley, Deepak Bhole, et al.
Leukemia
|
July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih-Feng Cho, Lijie Xing, et al.
The Journal of Clinical Investigation
|
March 5, 2013
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M Roccaro, Antonio Sacco, Patricia Maiso, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 15, 2016
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda, Loredana Santo, Marc N Wein, et al.
Blood
|
December 3, 2003
GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment
Klaus Podar, Laurence P Catley, Yu-Tzu Tai, et al.
Cancer Research
|
March 15, 2024
Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications
Yu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Blood
|
July 1, 2006
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Masood A Shammas, Paola Neri, Hemanta Koley, et al.
Cancer Research
|
June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma
Jing Zhang, Martin Sattler, Giovanni Tonon, et al.
Cancer Research
|
April 17, 2004
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications
Yu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy
Weihua Song, Hans J J van der Vliet, Yu-Tzu Tai, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 211) with videos related to
Sort By:
Page
of 22
British Journal of Haematology
|
July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
Reshma Shringarpure, Laurence Catley, Deepak Bhole, et al.
Leukemia
|
July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih-Feng Cho, Lijie Xing, et al.
The Journal of Clinical Investigation
|
March 5, 2013
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M Roccaro, Antonio Sacco, Patricia Maiso, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 15, 2016
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda, Loredana Santo, Marc N Wein, et al.
Blood
|
December 3, 2003
GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment
Klaus Podar, Laurence P Catley, Yu-Tzu Tai, et al.
Cancer Research
|
March 15, 2024
Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications
Yu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Blood
|
July 1, 2006
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Masood A Shammas, Paola Neri, Hemanta Koley, et al.
Cancer Research
|
June 11, 2009
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma
Jing Zhang, Martin Sattler, Giovanni Tonon, et al.
Cancer Research
|
April 17, 2004
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications
Yu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy
Weihua Song, Hans J J van der Vliet, Yu-Tzu Tai, et al.
Page
of 22